Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over

The topic routing was discussed at the Topic Selection Oversight Panel (TSOP) in November 2022. The panel concluded that the topic was suitable for a Technology Appraisal.  Please see project documents for further details. The evaluation is expected to begin with an invitation to participate in January 2023 with a first committee meeting in September 2023.

This page was last updated: 20 February 2023